Cargando…
The efficacy and safety of neoadjuvant nimotuzumab for gastric cancer: A meta-analysis of randomized controlled studies: Erratum
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772623/ https://www.ncbi.nlm.nih.gov/pubmed/35060564 http://dx.doi.org/10.1097/MD.0000000000028670 |
| _version_ | 1784635885347667968 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8772623 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87726232022-01-21 The efficacy and safety of neoadjuvant nimotuzumab for gastric cancer: A meta-analysis of randomized controlled studies: Erratum Medicine (Baltimore) Erratum Lippincott Williams & Wilkins 2022-01-21 /pmc/articles/PMC8772623/ /pubmed/35060564 http://dx.doi.org/10.1097/MD.0000000000028670 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) |
| spellingShingle | Erratum The efficacy and safety of neoadjuvant nimotuzumab for gastric cancer: A meta-analysis of randomized controlled studies: Erratum |
| title | The efficacy and safety of neoadjuvant nimotuzumab for gastric cancer: A meta-analysis of randomized controlled studies: Erratum |
| title_full | The efficacy and safety of neoadjuvant nimotuzumab for gastric cancer: A meta-analysis of randomized controlled studies: Erratum |
| title_fullStr | The efficacy and safety of neoadjuvant nimotuzumab for gastric cancer: A meta-analysis of randomized controlled studies: Erratum |
| title_full_unstemmed | The efficacy and safety of neoadjuvant nimotuzumab for gastric cancer: A meta-analysis of randomized controlled studies: Erratum |
| title_short | The efficacy and safety of neoadjuvant nimotuzumab for gastric cancer: A meta-analysis of randomized controlled studies: Erratum |
| title_sort | efficacy and safety of neoadjuvant nimotuzumab for gastric cancer: a meta-analysis of randomized controlled studies: erratum |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772623/ https://www.ncbi.nlm.nih.gov/pubmed/35060564 http://dx.doi.org/10.1097/MD.0000000000028670 |